FDA 510(k)

Visaris Vision® (Vision C, Vision U. Vision V, Vision X)

N.º K: K160620 · 2016-03-30

Fecha de decisión2016-03-30

Código de productoKPR

Comité asesorRA

DecisiónSubstantially Equivalent

Resumen del dispositivo

Visaris Vision® (Vision C, Vision U. Vision V, Vision X) is the device name listed in this FDA 510(k) record. The listed applicant is Visaris D.O.O. Belgrade. It received FDA 510(k) clearance on 2016-03-30 under 510(k) number K160620. The device is classified under product code KPR. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Visaris Vision® (Vision C, Vision U. Vision V, Vision X)?

Visaris Vision® (Vision C, Vision U. Vision V, Vision X) is a medical device that received FDA 510(k) clearance on 2016-03-30. The listed applicant is Visaris D.O.O. Belgrade. The 510(k) number is K160620.

When did Visaris Vision® (Vision C, Vision U. Vision V, Vision X) receive FDA 510(k) clearance?

Visaris Vision® (Vision C, Vision U. Vision V, Vision X) received FDA 510(k) clearance on 2016-03-30, under 510(k) number K160620.

Who is the listed applicant for Visaris Vision® (Vision C, Vision U. Vision V, Vision X)?

The FDA 510(k) record lists Visaris D.O.O. Belgrade as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Visaris Vision® (Vision C, Vision U. Vision V, Vision X)?

The FDA product code for Visaris Vision® (Vision C, Vision U. Vision V, Vision X) is KPR.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Dispositivos relacionados (Código: KPR)

K260227EXSYS DEXi (EXSYS DEXi-S40S); EXSYS DEXi (EXSYS DEXi-S40P); EXSYS DEXi (EXSYS DEXi-S40T); EXSYS DEXi (EXSYS DEXi-S50HDRTECH Corporation K260488MULTIX Impact; MULTIX Impact CSiemens Medical Solutions USA, Inc.K260481GC85ASamsung Electronics Co., Ltd.K260482DRE DuoJpi Healthcare Co, Ltd.K253446AeroDR TX c02Dk Medical Systems Co., Ltd.K250954DRX-Evolution Plus X-ray System, DRX-Compass Mobile X-ray System, Lux HD 35 detector, Lux HD 43 detectorCarestream Health

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.